Decreased serum level of NGF in alcohol-dependent patients with declined executive function

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 2153-2157

  Bae, Hwallip ^a   Ra, Youngsun ^a   Han, Changwoo ^b   Kim, Dai Jin ^c  

^a Hanyang Medical Center   (South Korea)

^b Keyo Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Alcohol dependence; Executive function; Nerve growth factor; Trail making test

Indexed keywords

ALCOHOL; LORAZEPAM; NERVE GROWTH FACTOR; PYRIDOXINE; THIAMINE; ZOLPIDEM;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FUNCTION TEST; HUMAN; MALE; NERVE CELL LESION; NEUROPSYCHOLOGICAL TEST; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST;

EID: 84910114787     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S72067     Document Type: Article

References (32)

1. Eckardt MJ, Stapleton JM, Rawlings RR, Davis EZ, Grodin DM. Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age. Am J Psychiatry. 1995;152(1):53-59.
2. Kopera M, Wojnar M, Brower K, et al. Cognitive functions in abstinent alcohol-dependent patients. Alcohol. 2012;46(7):665-671.
3. Fein G, Bachman L, Fisher S, Davenport L. Cognitive impairments in abstinent alcoholics. West J Med. 1990;152(5):531-537.
4. Tateno M, Saito T. Biological studies on alcohol-induced neuronal damage. Psychiatry Investig. 2008;5(1):21-27.
5. Miller MW. Limited ethanol exposure selectively alters the proliferation of precursor cells in the cerebral cortex. Alcohol Clin Exp Res. 1996; 20(1):139-143.
6. Nixon K, Crews FT. Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J Neurochem. 2002;83(5):1087-1093.
7. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev. 1998;27(1):1-39.
8. Seabold GK, Luo J, Miller MW. Effect of ethanol on neurotrophinmediated cell survival and receptor expression in cultures of cortical neurons. Brain Res Dev Brain Res. 1998;108(1-2):139-145.
9. Heaton MB, Mitchell JJ, Paiva M. Overexpression of NGF ameliorates ethanol neurotoxicity in the developing cerebellum. J Neurobiol. 2000;45(2):95-104.
10. Moore DB, Madorsky I, Paiva M, Barrow Heaton M. Ethanol exposure alters neurotrophin receptor expression in the rat central nervous system: effects of prenatal exposure. J Neurobiol. 2004;60(1):101-113.
11. Moore DB, Madorsky I, Paiva M, Barrow Heaton M. Ethanol exposure alters neurotrophin receptor expression in the rat central nervous system: effects of neonatal exposure. J Neurobiol. 2004;60(1):114-126.
12. Heberlein A, Bleich S, Bayerlein K, et al. NGF plasma levels increase due to alcohol intoxication and decrease during withdrawal. Psychoneuroendocrinology. 2008;33(7):999-1003.
13. Yoon SJ, Roh S, Lee H, et al. Possible role of nerve growth factor in the pathogenesis of alcohol dependence. Alcohol Clin Exp Res. 2006;30(6):1060-1065.
14. Jockers-Scherübl MC, Bauer A, Kuhn S, et al. Nerve growth factor in serum is a marker of the stage of alcohol disease. Neurosci Lett. 2007; 419(1):78-82.
15. Lukoyanov NV, Pereira PA, Paula-Barbosa MM, Cadete-Leite A. Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol. Exp Brain Res. 2003;148(1):88-94.
16. Crowe SF. The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the Trail Making Test. J Clin Psychol. 1998;54(5):585-591.
17. Miner T, Ferraro FR. The role of speed of processing, inhibitory mechanisms, and presentation order in trail-making test performance. Brain Cogn. 1998;38(2):246-253.
18. Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000;22(4):518-528.
19. Gaudino EA, Geisler MW, Squires NK. Construct validity in the Trail Making Test: what makes Part B harder? J Clin Exp Neuropsychol. 1995;17(4):529-535.
20. Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, et al. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009;15(3):438-450.
21. Periáñez JA, Ríos-Lago M, Rodríguez-Sánchez JM, et al. Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data. Arch Clin Neuropsychol. 2007;22(4):433-447.
22. Stuss DT, Bisschop SM, Alexander MP, Levine B, Katz D, Izukawa D. The Trail Making Test: a study in focal lesion patients. Psychol Assess. 2001;13(2):230-239.
23. Aloe L, Rocco ML, Bianchi P, Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med. 2012;10:239.
24. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Gene Brain Behav. 2008;7 Suppl 1: 43-56.
25. White HK, Levin ED. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease. Psychopharmacology. 1999;143(2):158-165.
26. French KL, Granholm AC, Moore AB, Nelson ME, Bimonte-Nelson HA. Chronic nicotine improves working and reference memory performance and reduces hippocampal NGF in aged female rats. Behav Brain Res. 2006;169(2):256-262.
27. Hernandez CM, Terry AV Jr. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor. Neuroscience. 2005;130(4):997-1012.
28. Health Quality Ontario. Vitamin B12 and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(23): 1-45.
29. Lu’o’ng KV, Nguyen LT. The beneficial role of vitamin D in Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2011;26(7):511-520.
30. Olson CR, Mello CV. Significance of vitamin A to brain function, behavior and learning. Mol Nutr Food Res. 2010;54(4):489-495.
31. Lane JT. The role of retinoids in the induction of nerve growth factor: a potential treatment for diabetic neuropathy. Transl Res. 2014;164(3):193-195.
32. Scalabrino G, Mutti E, Veber D, et al. Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency. Neurosci Lett. 2006;396(2):153-158.